Modeled hCGresist For Risk of Methotrexate Resistance/Failure

For patients with low-risk Gestational Trophoblastic Neoplasias treated with 8-day Methotrexate regimen.

hCGresist is calculated with minimum 4 values of hCG measured during the first 50 days after start of chemotherapy.